Latest news
Oculis to Buy Accure's Global Development, Commercial Rights to Privosegtor - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 08:45:17 GMTOculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 07:30:00 GMTOculis Holding AG (OCS) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Sat, 08 Aug 2026 15:59:37 GMTOculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 02:35:00 GMTOculis Reports Q2 2026 Financial Results and Provides Company Update - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:05:00 GMTEarnings To Watch: Oculis Holding AG (OCS) Reports Q2 2026 Result - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:33:43 GMTOculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 08:00:00 GMT